Assessment of Serosurveys for H5N1TONER, Eric S; ADALJA, Amesh A; NUZZO, Jennifer B et al.Clinical infectious diseases. 2013, Vol 56, Num 9, pp 1206-1212, issn 1058-4838, 7 p.Article

A Single-Dose Influenza A (H5N1) Vaccine Safe and Immunogenic in Adult and Elderly Patients: an Approach to Pandemic Vaccine DevelopmentVAJO, Zoltan; WOOD, John; KOSA, Lajos et al.Journal of virology. 2010, Vol 84, Num 3, pp 1237-1242, issn 0022-538X, 6 p.Article

Neuraminidase Inhibitor Susceptibility Network position statement : antiviral resistance in influenza A/H5N1 virusesHAYDEN, Frederick; KLIMOV, Alexander; ZAMBON, Maria et al.Antiviral therapy (London). 2005, Vol 10, Num 8, pp 873-877, issn 1359-6535, 5 p.Article

The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two citiesTO, Kelvin K. W; CHAN, Jasper F.W; HONGLIN CHEN et al.Lancet. Infectious diseases (print). 2013, Vol 13, Num 9, pp 809-821, issn 1473-3099, 13 p.Article

H5N1 Avian Influenza in ChildrenFAIK ONER, Ahmet; DOGAN, Nazim; BAMGBOYE, Ebun et al.Clinical infectious diseases. 2012, Vol 55, Num 1, pp 26-32, issn 1058-4838, 7 p.Article

Regional collaboration in the Middle East to deal with H5N1 avian fluLEVENTHAL, Alex; RAMLAWI, Assad; BELBIESI, Adel et al.BMJ. British medical journal (International ed.). 2006, Vol 333, Num 7573, pp 856-858, issn 0959-8146, 3 p.Article

Engineered H5N1: A Rare Time for Restraint in ScienceINGLESBY, Thomas V.Annals of internal medicine. 2012, Vol 156, Num 6, pp 460-462, issn 0003-4819, 3 p.Article

Co-circulation of two sublineages of HPAI H5N1 virus in the Kingdom of Saudi Arabia with unique molecular signatures suggesting separate introductions into the commercial poultry and falconry sectorsMONNE, Isabella; FUSARO, Alice; CATTOLI, Giovanni et al.Journal of general virology. 2008, Vol 89, pp 2691-2697, issn 0022-1317, 7 p., 11Article

Human infection with highly pathogenic H5N1 influenza virus. CommentariesSTEIN, James H; CURRIER, Judith S; NGUYEN TRAN HIEN et al.Lancet (British edition). 2008, Vol 371, Num 9622, issn 0140-6736, 1392-1394, 1464-1475 [15 p.]Article

Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenzaPRABHU, Nayana; PRABAKARAN, Mookkan; QIAN HONGLIANG et al.Antiviral therapy (London). 2009, Vol 14, Num 7, pp 911-921, issn 1359-6535, 11 p.Article

A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell CultureEHRLICH, Hartmut J; MÜLLER, Markus; VARTIAN, Nina et al.The New England journal of medicine. 2008, Vol 358, Num 24, pp 2573-2584, issn 0028-4793, 12 p.Article

Neutrophils May Be a Vehicle for Viral Replication and Dissemination in Human H5N1 Avian InfluenzaYINGYING ZHAO; MIN LU; JIANG GU et al.Clinical infectious diseases. 2008, Vol 47, Num 12, pp 1575-1578, issn 1058-4838, 4 p.Article

H5N1 infection of the respiratory tract and beyond : a molecular pathology study. CommentaryWAI FU NG; KA FAI TO; ZIFEN GAO et al.Lancet (British edition). 2007, Vol 370, Num 9593, issn 0140-6736, 1106-1108, 1137-1145 [12 p.]Article

Issues Relevant to the Adoption and Modification of Hospital Infection-Control Recommendations for Avian Influenza (H5N1 Infection) in Developing CountriesAPISARNTHANARAK, Anucha; WARREN, David K; FRASER, Victoria J et al.Clinical infectious diseases. 2007, Vol 45, Num 10, pp 1338-1342, issn 1058-4838, 5 p.Article

Cytotoxic therapy for severe avian influenza A (H5N1) infectionHENTER, Jan-Inge; CHOW, Chun-Bong; LEUNG, Chi-Wai et al.Lancet (British edition). 2006, Vol 367, Num 9513, pp 870-873, issn 0140-6736, 4 p.Article

Clinical Features of Human Influenza A (H5N1) Infection in Vietnam: 2004―2006NGUYEN THANH LIEM; CAO VIET TUNG; FARRAR, Jeremy et al.Clinical infectious diseases. 2009, Vol 48, Num 12, pp 1639-1646, issn 1058-4838, 8 p.Article

GENETIC CHARACTERIZATION OF NONSTRUCTURAL GENES OF H5N1 AVIAN INFLUENZA VIRUSES ISOLATED IN THAILAND IN 2004-2005SUWANNAKHON, Narutchala; POOKORN, Sarutsawadee; SANGUANSERMSRI, Donruedee et al.Southeast Asian journal of tropical medicine and public health. 2008, Vol 39, Num 5, pp 837-847, issn 0125-1562, 11 p.Article

In vitro and in vivo protection against the highly pathogenic H5N1 influenza virus by an antisense phosphorothioate oligonucleotideMING DUAN; ZHE ZHOU; LIN, Ru-Xian et al.Antiviral therapy (London). 2008, Vol 13, Num 1, pp 109-114, issn 1359-6535, 6 p.Article

HUMAN INFLUENZA A/H5N1 (PRE-PANDEMIC) VACCINES : INFORMING POLICY DEVELOPMENT IN EUROPETEAM, Influenza.Euro surveillance. 2007, Vol 12, Num 7-9, pp 264-265, issn 1025-496X, 2 p.Article

Risk Factors for Cluster Outbreaks of Avian Influenza A H5N1 Infection, IndonesiaADITAMA, Tjandra Y; SAMAAN, Gina; COOK, Alex R et al.Clinical infectious diseases. 2011, Vol 53, Num 12, pp 1237-1244, issn 1058-4838, 8 p.Article

Evaluation of Twenty Rapid Antigen Tests for the Detection of Human Influenza A H5N1, H3N2, H1N1, and B VirusesTAYLOR, Janette; MCPHIE, Kenneth; DRUCE, Julian et al.Journal of medical virology. 2009, Vol 81, Num 11, pp 1918-1922, issn 0146-6615, 5 p.Article

Pathogenicity and Vaccine Efficacy of Different Clades of Asian H5N1 Avian Influenza A Viruses in Domestic DucksKIM, Jeong-Ki; SEILER, Patrick; GOVORKOVA, Elena A et al.Journal of virology. 2008, Vol 82, Num 22, pp 11374-11382, issn 0022-538X, 9 p.Article

Three indonesian clusters of H5N1 virus infection in 2005NYOMAN KANDUN, I; WIBISONO, Hariadi; YUWONO, Djoko et al.The New England journal of medicine. 2006, Vol 355, Num 21, pp 2186-2194, issn 0028-4793, 9 p.Article

Adaptations of Avian Flu Virus Are a Cause for ConcernBERNS, Kenneth I; CASADEVALL, Arturo; KANABROCKI, Joseph et al.Science (Washington, D.C.). 2012, Vol 335, Num 6069, pp 660-661, issn 0036-8075, 2 p.Article

Properties and Therapeutic Efficacy of Broadly Reactive Chimeric and Humanized H5-Specific Monoclonal Antibodies against H5N1 Influenza VirusesQINGBING ZHENG; LIN YIA; HONGLIN CHEN et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 4, pp 1349-1357, issn 0066-4804, 9 p.Article